W.A.R.F. 42 en es it fr

W.A.R.F. 42 Brand names, W.A.R.F. 42 Analogs

W.A.R.F. 42 Brand Names Mixture

  • No information avaliable

W.A.R.F. 42 Chemical_Formula


W.A.R.F. 42 RX_link


W.A.R.F. 42 fda sheet

W.A.R.F._42 FDA

W.A.R.F. 42 msds (material safety sheet)

W.A.R.F._42 MSDS

W.A.R.F. 42 Synthesis Reference

Stahmann, et al., U.S. Pat. 2,427,578 (1947)

W.A.R.F. 42 Molecular Weight

308.328 g/mol

W.A.R.F. 42 Melting Point

161 oC

W.A.R.F. 42 H2O Solubility

17 mg/L

W.A.R.F. 42 State


W.A.R.F. 42 LogP


W.A.R.F. 42 Dosage Forms

Powder for solution; Tablet

W.A.R.F. 42 Indication

For the treatment of retinal vascular occlusion, pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, transient cerebral ischaemia, arterial embolism and thrombosis.

W.A.R.F. 42 Pharmacology

Warfarin, a coumarin anticoagulant, is a racemic mixture of two active isomers. It is used in the prevention and treatment of thromboembolic disease including venous thrombosis, thromboembolism, and pulmonary embolism as well as for the prevention of ischemic stroke in patients with atrial fibrillation (AF).

W.A.R.F. 42 Absorption

No information avaliable

W.A.R.F. 42 side effects and Toxicity

LD50=374 (orally in mice)

W.A.R.F. 42 Patient Information

No information avaliable

W.A.R.F. 42 Organisms Affected

Humans and other mammals